Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
BIOVAIL AMERICAS CORP. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2012 | EBSA | $10,001 |
Parexel International, LLC | Parexel International | pharmaceuticals | labor relations violation | 2012 | NLRB | $253,000 |
Novartis | Novartis | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Genentech | Roche | pharmaceuticals | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
Hoffmann-La Roche, Inc. | Roche | pharmaceuticals | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
Actavis | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Boehringer Ingelheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Forest Laboratories, Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $790,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $181,000,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $625,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Sanofi-Aventis U.S. LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $828,500 |
Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
Advanced Sterilization Products | Johnson & Johnson | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $25,616 |
Pfizer Inc. | Pfizer | pharmaceuticals | pesticide violation | 2012 | CA-DPR | $6,720 |
Abraxis Bioscience, Inc. | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2012 | CA-SCAQMD | $5,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $57,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2012 | private lawsuit-state | $39,000,000 |
PFIZER, INC. | Pfizer | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $9,600 |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $10,115 |
ALEXION PHARMACEUTICALS, INC. | AstraZeneca | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $8,213 |
MERCK SHARP & DOHME CORPORATION | Merck | pharmaceuticals | environmental violation | 2012 | EPA | $69,274 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | hazardous waste violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
Merck | Merck | pharmaceuticals | environmental violation | 2011 | EPA | $1,500,000 |
Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | pharmaceuticals | air pollution violation | 2011 | EPA | $300,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
CHEROKEE PHARMACEUTICALS LLC | Merck | pharmaceuticals | benefit plan administrator violation | 2011 | EBSA | $10,001 |
Amgen, Inc. | Amgen | pharmaceuticals | labor relations violation | 2011 | NLRB | $40,000 |
Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2011 | USAO | $1,725,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | pharmaceuticals | aviation safety violation | 2011 | FAA | $30,000 |
Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
Genentech | Roche | pharmaceuticals | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
Boehringer Ingleheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Dey Pharmaceuticals | Viatris | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
Merck & Co., Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Merck and Company, Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Par Pharmaceutical Co. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Cos., Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $750,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Schering-Plough Healthcare Products Inc. | Merck | pharmaceuticals | pesticide violation | 2011 | CA-DPR | $28,400 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
Mallinckrodt/Covidien | Mallinckrodt | pharmaceuticals | air pollution violation | 2011 | MO-ENV | $6,000 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | pharmaceuticals | hazardous waste violation | 2011 | NJ-ENV | $25,000 |
PHIBRO-TECH, INC | Phibro Animal Health | pharmaceuticals | hazardous waste violation | 2011 | SC-ENV | $15,000 |
Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | pharmaceuticals | air pollution violation | 2011 | CA-SCAQMD | $12,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Amgen Inc. | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Fujisawa Healthcare, Inc. | Astellas Pharma | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Hoechst Marion Roussel | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Immunex Corporation | Amgen | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Mylan Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
Pharmacia Corporation | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |